Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Proactive Investors" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Proactive Investors for you to read. Along with our medical data and news we also list Proactive Investors Clinical Trials, which are updated daily. BioPortfolio also has a large database of Proactive Investors Companies for you to search.
Liberum analyst Yuan Low says it is still early on in graphene’s development, but he has “no doubt” over its “wonder material” status and its potential further down the line
Faz Chowdhury, chief executive of Nemaura Medical Inc (NASDAQ:NMRD), spoke to Proactive London's Andrew Scott to update on their European and FDA trials as work continues towards the launch in the UK of their non-invasive glucose monitor by the end of the year. ''We believe it'll be the world's first non-invasive glucose monitoring system''. ''It's a continuous monitor, you place it on the a...
Final analysis identifies patients with triple negative breast cancer (TNBC) as the key target patient population for the drug.
Its drug Anavex2-73 is being developed to treat Rett Syndrome, a rare neurological disorder that occurs mainly in girls and can lead to severe impairments
Respiratory syncytial virus causes the common cold, for which there is no effective cure.
For the first nine months of 2018, the businesses Essentra is looking to exit made an operating loss of around £1mln. The closures would result in an exceptional charge in the second half of 2018 of about £12mln, of which roughly £4mln would be a cash charge
The acquisition provides Dechra with a “strategically important presence” in Brazil, the fourth largest livestock market in the world
Successful registration with the DEA by its partner Transdermal cracks the door to begin formula development of a dronabinol transdermal patch
As a result of the IPO, the value of Arix’s stake in LogicBio has soared to almost £23mln, including the extra investment announced today
Three directors have subscribed for shares. Two independent directors have consulted with Futura's nomad and deemed that the terms of the participating directors' participation in the subscription is "fair and reasonable"
The small-cap biotech appears to have addressed any need for a deep-pocketed partner while it develops not one but two potential blockbuster therapies
The company announced Thursday it has been granted two new US patents related to cannabinoid infused beverage compositions
Aethlon Medical Inc (NASDAQ:AEMD) CEO Jim Joyce spoke with Proactive Investor's Christine Corrado at the BIO Investor Forum in San Francisco. The San Diego based company is focused on addressing unmet needs in global health and biodefense with the Aethlon Hemopurifier, a therapeutic device designed for the rapid depletion of circulating viruses and cancer promoting exosomes.
Berlin Cures Holding AG President Joannes Müller and COO Peter Göttel sit down with Proactive Investors' Christine Corrado at the BIO Investor Summit in San Francisco. Berlin Cures Holding AG is a life science company, located in Zug, Switzerland with an R&D-branch in Berlin, Germany.
Sernova Corp (TSX-V: SVA, OTCQB: SEOVF) CEO Philip Toleikis sat down with Proactive Investors' Christine Corrado at the BIO Investor Forum in San Francisco. Sernova focuses on developing medical devices and products for patients suffering from chronic metabolic, neurological, and haematological diseases. The company's flagship product is its Cell Pouch system, a medical device which forms a ...
Hillstream BioPharma CEO Randy Milby sits down with Proactive Investors' Christine Corrado at the BIO Investor Forum in San Francisco. Hillsteam BioPharma is developing targeted cancer therapeutics designed to be safer and more efficacious than currently available chemo-therapies.
Bryan Oronsky and James Brown from EpicentRx sit down with Christine Corrado at the BIO Investor Forum in San Francisco. EpicentRx is a biotechnology company developing a next-generation immunotherapy platform of viruses that infect and kill cancer cells for the treatment of several tumor types.
Novartis will use its resources to develop an Endocyte treatment for prostate cancer
Chairman Peter Presland will take on a more active role to free up more time for CEO João Andrade to focus on sales and business development
ChemioCare USA Inc CEO Pedro Lichtinger sits down with Proactive Investors' Christine Corrado at the BIO Investor Forum in San Francisco. Lichtinger says the New York based company, which is aiming to transform patient outcomes in cancer supportive care through its platform of transdermal patches using proprietary technology, says the company has completed its first proof of concept in animals...
Sativa Investments has taken a big step towards becoming the UK's first seed to consumer medicinal cannabis business
The patent covers methods of use for its omega-3 fatty acid therapy, which is in development for the treatment of heart conditions and high cholesterol
Epygen Group President Debayan Ghosh sits down with Christine Corrado at the BIO Investor Forum in San Francisco. Epygen is a biotechnology organization, headquartered in Dubai, UAE, with offices, labs and manufacturing facilities in Dubai, India, and the US. Epygen conducts research and manufacturing of a wide range of enzymes proteins for the therapeutic as well as industrial enzyme space.
Zynerba Pharmaceuticals (NASDAQ:ZYNE) CEO Armando Anido caught up with Proactive Investors' Christine Corrado at the BIO Investor Forum in San Francisco. Zynerba is dedicated to developing next-generation transdermally-delivered cannabinoid therapeutics for rare and near-rare neuropsychiatric conditions in patients with high unmet medical needs.
Michael Hunt, CFO at Reneuron Plc (LON:RENE), spoke to Proactive ahead of new data being presented at the 26th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) relating to its CTX stem cell platform. The platform is currently being taken through the clinic as a possible treatment for stroke patients, with long-term data suggesting it can improvement motor function and r...